NO980215L - Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater - Google Patents

Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater

Info

Publication number
NO980215L
NO980215L NO980215A NO980215A NO980215L NO 980215 L NO980215 L NO 980215L NO 980215 A NO980215 A NO 980215A NO 980215 A NO980215 A NO 980215A NO 980215 L NO980215 L NO 980215L
Authority
NO
Norway
Prior art keywords
derivatives
pharmaceutical compositions
compositions containing
drugs
preparation
Prior art date
Application number
NO980215A
Other languages
English (en)
Other versions
NO980215D0 (no
Inventor
Claude Thal
Cathrine Guillou
Aude Mary
Dolor Renko
Pierre Potier
Yves Christen
Original Assignee
Sod Conseils Rech Applic
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sod Conseils Rech Applic filed Critical Sod Conseils Rech Applic
Publication of NO980215L publication Critical patent/NO980215L/no
Publication of NO980215D0 publication Critical patent/NO980215D0/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Nye galantamin-derivater med de generelle formler (la) og (lb), en fremgangsmåte for fremstilling derav, farmasøytiske preparater inneholdende nevnte derivater og anvendelse av dem, spesielt som cholinesterase-inhibitorer, er beskrevet.
NO980215A 1995-07-19 1998-01-16 Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater NO980215D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9514821.9A GB9514821D0 (en) 1995-07-19 1995-07-19 Galanthamine derivatives
PCT/FR1996/001139 WO1997003987A1 (fr) 1995-07-19 1996-07-19 Nouveaux derives de la galanthamine, leur procede de preparation, leur application comme medicaments et les compositions pharmaceutiques les renfermant

Publications (2)

Publication Number Publication Date
NO980215L true NO980215L (no) 1998-01-16
NO980215D0 NO980215D0 (no) 1998-01-16

Family

ID=10777948

Family Applications (1)

Application Number Title Priority Date Filing Date
NO980215A NO980215D0 (no) 1995-07-19 1998-01-16 Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater

Country Status (16)

Country Link
US (1) US5958903A (no)
EP (1) EP0839149B9 (no)
JP (1) JP4177894B2 (no)
AT (1) ATE264332T1 (no)
AU (1) AU6662396A (no)
CA (1) CA2227235C (no)
DE (1) DE69632194T2 (no)
DK (1) DK0839149T3 (no)
ES (1) ES2218596T3 (no)
GB (1) GB9514821D0 (no)
IL (1) IL122739A0 (no)
MX (1) MX9800407A (no)
NO (1) NO980215D0 (no)
PT (1) PT839149E (no)
WO (1) WO1997003987A1 (no)
ZA (1) ZA966163B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU758802B2 (en) * 1998-09-30 2003-03-27 Takeda Pharmaceutical Company Limited Drugs for improving vesical excretory strength
WO2000030446A1 (en) * 1998-11-23 2000-06-02 Bonnie Davis Dosage formulations for acetylcholinesterase inhibitors
EA004936B1 (ru) 1998-12-24 2004-10-28 Янссен Фармацевтика Н.В. Препаративная форма галантамина с регулируемым выделением
AU2504200A (en) * 1999-01-11 2000-08-01 Atanas Russinov Djananov Herbal supplement for increased muscle strength and endurance for athletes
US8603546B2 (en) * 1999-01-11 2013-12-10 Herbaceuticals Inc. Herbal supplement for increased muscle strength and endurance for athletes
WO2000059544A1 (fr) * 1999-03-31 2000-10-12 Eisai Co., Ltd. Compositions stabilisees contenant des medicaments nootropes
HUP0202233A3 (en) * 2000-03-31 2004-12-28 Sanochemia Pharmazeutika Ag Derivatives and analogues of galanthamin, their use, pharmaceutical compositions containing them and process for the preparation of them
DE10129265A1 (de) * 2001-06-18 2003-01-02 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Sucht- oder Rauschmitteltherapie
JP4721386B2 (ja) * 2001-07-10 2011-07-13 第一三共株式会社 新規ガランタミン類縁体
DE10134038A1 (de) * 2001-07-12 2003-02-06 Hf Arzneimittelforsch Gmbh Wirkstoff-Kombination zur medikamentösen Therapie der Nikotinabhängigkeit
US20060069251A1 (en) * 2002-03-25 2006-03-30 Ulrich Jordis Methods for producing norgalanthamine, as well as isomers, salts and hydrates thereof
AT414125B (de) * 2003-09-29 2006-09-15 Sanochemia Pharmazeutika Ag Neue derivate des 4a,5,9,10,11,12-hexahydro- benzofuro(3a,3,2)(2) benzazepin, verfahren zu deren herstellung sowie deren verwendung zur herstellung von arzneimitteln
MXPA05005570A (es) * 2003-09-29 2005-10-18 Sanochemia Pharmazeutika Ag Uso de galantamina y los derivados de la misma en la produccion de medicamentos.
WO2005065662A1 (en) * 2003-12-31 2005-07-21 Actavis Group Hf Solid dosage formulations of galantamine
EP1763337A2 (en) * 2003-12-31 2007-03-21 Actavis Group HF Immediate, controlled and sustained release formulations of galanthamine
ATE478659T1 (de) * 2005-05-13 2010-09-15 Alza Corp Mehrlagiges arzneimittelausbringsystem mit sperre gegen reservoirmaterialfluss
US20070104771A1 (en) * 2005-09-23 2007-05-10 Jay Audett Transdermal galantamine delivery system
US20110171332A1 (en) * 2008-09-11 2011-07-14 I.B.R. Israeli Biotechnology Research Ltd. Leucojum bulb extracts and use thereof
US20120129838A1 (en) * 2009-04-24 2012-05-24 The Industry & Academic Cooperation In Chungnam National University Composition for Preventing and Treating Alopecia Disorder Containing Morgalanthamine Compounds as an Active Ingredient

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4663318A (en) * 1986-01-15 1987-05-05 Bonnie Davis Method of treating Alzheimer's disease
US4735169A (en) * 1986-09-03 1988-04-05 Nordson Corporation Adhesive applicator assembly
WO1988008708A1 (en) * 1987-05-04 1988-11-17 Bonnie Davis Compounds for the treatment of alzheimer's disease
US5336675A (en) * 1991-05-14 1994-08-09 Ernir Snorrason Method of treating mania in humans
US6323195B1 (en) * 1993-10-15 2001-11-27 Aventis Pharmaceuticals Inc. Galanthamine derivatives as acetylcholinesterase inhibitors
US5428159A (en) * 1994-04-08 1995-06-27 Ciba-Geigy Corporation Method of manufacture of (-)-galanthamine in high yield and purity substantially free of epigalanthamine

Also Published As

Publication number Publication date
WO1997003987A1 (fr) 1997-02-06
JP4177894B2 (ja) 2008-11-05
ZA966163B (en) 1997-02-10
IL122739A0 (en) 1998-08-16
MX9800407A (es) 1998-04-30
AU6662396A (en) 1997-02-18
CA2227235C (fr) 2010-08-31
DE69632194D1 (de) 2004-05-19
DK0839149T3 (da) 2004-08-09
ES2218596T3 (es) 2004-11-16
ATE264332T1 (de) 2004-04-15
US5958903A (en) 1999-09-28
DE69632194T2 (de) 2005-03-17
EP0839149B9 (fr) 2005-03-09
EP0839149B1 (fr) 2004-04-14
CA2227235A1 (fr) 1997-02-06
NO980215D0 (no) 1998-01-16
GB9514821D0 (en) 1995-09-20
JPH11509541A (ja) 1999-08-24
PT839149E (pt) 2004-08-31
EP0839149A1 (fr) 1998-05-06

Similar Documents

Publication Publication Date Title
NO980215L (no) Nye galantamin-derivater, fremgangsmåte for fremstilling derav, anvendelse derav som legemidler, og farmasöytiske blandinger inneholdende slike derivater
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
DK0706378T3 (da) Ny farmaceutisk formulering.
DK0553191T3 (da) Pyridin- og pyridin-N-oxidderivater af diarylmethylpiperidiner eller -piperaziner, præparater og an vendelse deraf
IS4226A (is) Hliðstæðar aðferðir við framleiðslu á nýjum (R)-5-karbamóýl-8-flúor-3-N,N-tvíútskiptum-amínó-3,4-díhýdró-2H-1-bensópýrönum
HUP9901304A3 (en) Piperazine and piperidine derivatives with analgesic effect, process for their preparation and pharmaceutical compositions containing them
DE122011100032I1 (de) Verwendung von n-substituierten pyridonen als tumornekrose-faktor alpha hemmer.
GEP20053501B (en) Core Tablet for Controlled Release of Gliclazide after Oral Administration
GEP20033028B (en) Heterocyclic Compounds as Inhibitors of Rotamase Enzymes, Method for Their Production, Pharmaceutical Composition Containing Them and Use Thereof
DE69632193D1 (de) Cyclooxygenaseinhibitor und salze von amidinderivaten, verfahren zu deren herstellung, deren verwendung als arzneiwirkstoffe sowie diese salze enthaltende arzneimittel
MY118828A (en) Substituted amino compounds and their use as substances having an analgesic effect
DE60121431D1 (de) Ein pyridin-n-oxid-derivat und ein prozess zu seiner umsetzung in pharmazeutische wirkstoffe
NO995685D0 (no) Nye glycosylerte ginkgolidderivater, anvendelse derav som medikamenter og farmasöytiske blandinger
NO20006547L (no) Salter av paroxetine
GEP20012518B (en) Novel Erythromycin Derivatives, Method for Their Preparation and Their Use as Medicine
DE69905490T2 (de) Benzofuranderivate, verfahren zu ihrer herstellung, ihre anwendung als medikament und sie enthaltende pharmazeutische zubereitungen
JO1880B1 (en) Format 1 for multi-unit calibration discs
NO930942D0 (no) Nye 17-beta-oestradiolderivater, fremgangsmaater for deres fremstilling og legemiddel inneholdende disse forbindelser
ATE221068T1 (de) Anellierte beta-carboline